Trademark: 90236132
Word
LASANTH
Status Date
Wednesday, May 29, 2024
Filing Date
Monday, October 5, 2020
Published for Opposition
Tuesday, April 6, 2021
35 Business consulting services in the field of regulatory compliance; business development services; business strategy development services; business consulting and management in the field of clinical trials, namely, regulatory submission management on behalf of medical, pharmaceutical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; regulatory submission management, namely, assisting others in preparing applications for medical technologies, medications, pharmaceutical, biopharmaceuticals, and biotechnology with governmental regulatory bodies around the world; regulatory submission management, namely, providing simultaneous multiple country submissions of applications for the registration and approval of medical technologies, medications, pharmaceutical, biopharmaceuticals, and biotechnology; providing information online regarding regulatory submission management; business management consulting, strategic planning and business advisory services provided to medical, medical technology, pharmaceutical, biopharmaceutical, and biotechnology companies, and government agencies, educational and research institutions, in the fields of biologics and pharmaceuticals; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for drug approval; regulatory submission management, namely, assisting others in preparing applications for new drugs with governmental regulatory bodies; business consulting services in the field of biologics and pharmaceuticals
45 Regulatory compliance consulting services, namely, reviewing standards and practices to assist clients with compliance with governmental laws, regulations and rules in the fields of medical technologies, medications, biopharmaceuticals, and biotechnology; providing technical regulatory affair consulting services directed to medical, medical technology, biopharmaceutical, and biotechnology companies in order to assure compliance with food and drug administration's laws and regulations; provision of information online pertaining to regulatory compliance in the fields of medical technologies, medications, biopharmaceuticals, and biotechnology; and regulatory compliance consulting in the fields of biologics and pharmaceuticals
42 Product research and development for others in the fields of biologics and pharmaceuticals; quality management services, namely, quality evaluation and analysis, quality assurance and quality control in the field of biologics and pharmaceuticals; scientific consulting and research services relating to the field of pharmaceuticals and life sciences, namely, biology, and medicine; consulting services in the fields of biotechnology and pharmaceuticals, namely, design, development, technical verification and technical validation of manufacturing and filling processes, drug formulations, testing protocols and analytical methods; scientific and technological services, namely, scientific research, analysis, testing, and related scientific studies in the field of chemistry and molecular biology, namely, biologics and protein detection, characterization, analysis and testing
Oct 8, 2020
New Application Entered
Nov 19, 2020
New Application Office Supplied Data Entered
Mar 2, 2021
Assigned To Examiner
Mar 2, 2021
Approved For Pub - Principal Register
Apr 6, 2021
Published For Opposition
Mar 17, 2021
Notification Of Notice Of Publication E-Mailed
Apr 6, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 1, 2021
Noa E-Mailed - Sou Required From Applicant
Sep 27, 2021
Sou Teas Extension Received
May 19, 2022
Sou Teas Extension Received
Sep 27, 2021
Sou Extension 1 Filed
Sep 27, 2021
Sou Extension 1 Granted
Sep 29, 2021
Notice Of Approval Of Extension Request E-Mailed
May 19, 2022
Sou Extension 2 Filed
May 19, 2022
Sou Extension 2 Granted
Oct 19, 2022
Sou Teas Extension Received
May 21, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 19, 2022
Sou Extension 3 Filed
Oct 19, 2022
Sou Extension 3 Granted
Oct 21, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 23, 2023
Sou Teas Extension Received
Apr 23, 2023
Sou Extension 4 Filed
Apr 23, 2023
Sou Extension 4 Granted
Oct 3, 2023
Case Assigned To Intent To Use Paralegal
Apr 25, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 26, 2023
Sou Teas Extension Received
Sep 26, 2023
Sou Extension 5 Filed
Oct 4, 2023
Sou Extension 5 Granted
Oct 5, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 26, 2024
Use Amendment Filed
Apr 26, 2024
Teas Statement Of Use Received
Apr 30, 2024
Statement Of Use Processing Complete
May 29, 2024
Su - Non-Final Action - Written
Jul 17, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 29, 2024
Non-Final Action E-Mailed
May 29, 2024
Notification Of Non-Final Action E-Mailed
Jul 17, 2024
Teas Change Of Correspondence Received
Jul 17, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 17, 2024
Teas Withdrawal Of Attorney Received-Firm Retains
Aug 12, 2024
Teas Response To Office Action Received
Trademark Alertz updated from USPTO on 2030-01-24
